Published in Proc Natl Acad Sci U S A on May 14, 2008
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol (2009) 3.13
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89
Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol (2011) 2.67
Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol (2013) 2.47
Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science (2013) 1.87
Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86
Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. J Immunol (2012) 1.69
Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol (2015) 1.57
Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal (2008) 1.57
Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov (2013) 1.47
Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci Signal (2008) 1.37
IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol (2008) 1.28
IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling. J Allergy Clin Immunol (2010) 1.20
Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung. J Allergy Clin Immunol (2009) 1.12
IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop. J Immunol (2013) 1.10
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma. Br J Pharmacol (2012) 1.10
Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med (2009) 1.07
IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med (2012) 1.06
Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice. Am J Pathol (2012) 1.00
Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrhea. J Allergy Clin Immunol (2008) 1.00
IL-13 receptor α1 differentially regulates aeroallergen-induced lung responses. J Immunol (2011) 0.98
IL-4 and IL-13 signaling in allergic airway disease. Cytokine (2015) 0.96
Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient mice. ASN Neuro (2009) 0.96
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther (2013) 0.95
In vivo regulation of the allergic response by the IL-4 receptor alpha chain immunoreceptor tyrosine-based inhibitory motif. J Allergy Clin Immunol (2010) 0.94
Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. J Biol Chem (2011) 0.94
Resistin-like molecule-α regulates IL-13-induced chemokine production but not allergen-induced airway responses. Am J Respir Cell Mol Biol (2012) 0.93
Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis. Am J Respir Cell Mol Biol (2008) 0.92
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice. J Immunol (2009) 0.92
IL-4 engagement of the type I IL-4 receptor complex enhances mouse eosinophil migration to eotaxin-1 in vitro. PLoS One (2012) 0.90
Transfer of in vivo primed transgenic T cells supports allergic lung inflammation and FIZZ1 and Ym1 production in an IL-4Rα and STAT6 dependent manner. BMC Immunol (2011) 0.90
Cutting edge: IL-13Rα1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J Immunol (2012) 0.89
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol (2008) 0.88
Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proc Natl Acad Sci U S A (2013) 0.87
Gene expression in whole lung and pulmonary macrophages reflects the dynamic pathology associated with airway surface dehydration. BMC Genomics (2014) 0.86
A meta-analysis of IL-13 polymorphisms and pediatric asthma risk. Med Sci Monit (2014) 0.85
Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation. J Immunol (2016) 0.85
Dupilumab: a novel treatment for asthma. J Asthma Allergy (2014) 0.85
The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. Cytokine (2015) 0.84
A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair. Mucosal Immunol (2015) 0.82
Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression. J Biol Chem (2015) 0.82
Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner. Infect Immun (2014) 0.82
Retinoic acid prevents mesenteric lymph node dendritic cells from inducing IL-13-producing inflammatory Th2 cells. Mucosal Immunol (2013) 0.81
Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators? Arthritis Res Ther (2012) 0.81
Cytokines in chronic respiratory diseases. F1000 Biol Rep (2013) 0.81
IL-13 overexpression in mouse lungs triggers systemic genotoxicity in peripheral blood. Mutat Res (2014) 0.80
Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics. Front Physiol (2013) 0.80
MicroRNA-143 downregulates interleukin-13 receptor alpha1 in human mast cells. Int J Mol Sci (2013) 0.79
The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13. J Biol Chem (2012) 0.79
The role of neuropeptide S and neuropeptide S receptor 1 in regulation of respiratory function in mice. Peptides (2010) 0.79
T helper subsets in allergic eye disease. Curr Opin Allergy Clin Immunol (2014) 0.79
New Role for Interleukin-13 Receptor α1 in Myocardial Homeostasis and Heart Failure. J Am Heart Assoc (2017) 0.78
Effects of 7,8-dihydro-8-oxo-deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of Rac. Br J Pharmacol (2009) 0.78
IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function. Eur J Immunol (2014) 0.78
Blockade of Airway Inflammation by Kaempferol via Disturbing Tyk-STAT Signaling in Airway Epithelial Cells and in Asthmatic Mice. Evid Based Complement Alternat Med (2013) 0.78
Neonatal Basophils Stifle the Function of Early-Life Dendritic Cells To Curtail Th1 Immunity in Newborn Mice. J Immunol (2015) 0.78
The impact of anti-inflammatory cytokines on the pancreatic β-cell. Islets (2014) 0.77
Low serum interleukin-13 levels correlate with poorer prognoses for colorectal cancer patients. Int Surg (2014) 0.77
The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4. J Innate Immun (2015) 0.77
Association of IL13R alpha 1 +1398A/G polymorphism in a North Indian population with asthma: A case-control study. Allergy Rhinol (Providence) (2015) 0.76
Effects of microRNA-21 on the interleukin 12/signal transducer and activator of transcription 4 signaling pathway in asthmatic mice. Cent Eur J Immunol (2014) 0.76
Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice. Inflammation (2014) 0.76
Transgenic modelling of cytokine polarization in the lung. Immunology (2010) 0.75
Associations of IL-4, IL-6, and IL-12 levels in peripheral blood with lung function, cellular immune function, and quality of life in children with moderate-to-severe asthma. Medicine (Baltimore) (2017) 0.75
IL-13 from intraepithelial lymphocytes regulates tissue homeostasis and protects against carcinogenesis in the skin. Nat Commun (2016) 0.75
Absence of the common gamma chain (γ(c)), a critical component of the Type I IL-4 receptor, increases the severity of allergic lung inflammation. PLoS One (2013) 0.75
Effect of TH2 cytokines and interferon gamma on beat frequency of human respiratory cilia. Pediatr Res (2016) 0.75
The Regulatory Function of Eosinophils. Microbiol Spectr (2016) 0.75
Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget (2017) 0.75
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66
IL-13 effector functions. Annu Rev Immunol (2001) 5.51
IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med (2005) 5.13
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
IL-4 is required to generate and sustain in vivo IgE responses. J Immunol (1988) 4.04
Interleukin-13 in asthma pathogenesis. Immunol Rev (2004) 3.69
Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med (1999) 3.40
Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J Immunol (1993) 3.29
IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol (2003) 2.79
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med (2003) 2.71
Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol (2005) 2.65
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med (2003) 2.54
Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol (2007) 2.50
Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol (2007) 1.69
Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol (1998) 1.60
Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation. J Exp Med (2001) 1.51
Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol (2006) 1.47
Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol (1997) 1.42
IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol (2001) 1.41
Natural IgE production in the absence of MHC Class II cognate help. Immunity (2006) 1.40
Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol Rev (2004) 1.37
Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses. J Immunol (2007) 1.29
IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol (2006) 1.25
Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci U S A (2004) 1.18
Interleukin-13 and leukotrienes: an intersection of pathogenetic schema. Am J Respir Cell Mol Biol (2003) 1.18
IL-4 induces in vivo production of IFN-gamma by NK and NKT cells. J Immunol (2006) 1.09
Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms. J Immunol (2006) 1.07
Interleukin-13: characterization and biologic properties. Cancer Treat Res (1995) 0.83
Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med (1990) 7.09
The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev (1988) 5.02
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci U S A (1986) 4.69
IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity (1998) 4.65
Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med (1993) 3.38
An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest (2001) 3.32
Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 3.10
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sci U S A (1991) 3.01
Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med (1994) 2.90
Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med (1988) 2.84
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med (1987) 2.69
The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev (1992) 2.69
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med (1996) 2.55
Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med (1995) 2.52
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci U S A (1991) 2.41
Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut (2010) 2.31
Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol (1981) 2.26
Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol (1994) 2.25
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc Natl Acad Sci U S A (1990) 2.18
IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol (1997) 2.09
Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest (1999) 2.05
IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J Immunol (1990) 2.03
Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A (1998) 1.98
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins. J Immunol (1981) 1.97
Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol (1982) 1.96
Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: evaluation by a modified reverse hemolytic plaque assay. J Immunol (1978) 1.93
Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol (1994) 1.92
IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma. Proc Natl Acad Sci U S A (1989) 1.89
Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol (1991) 1.87
Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol (1988) 1.84
Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response. J Immunol (1987) 1.82
Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect. J Exp Med (1975) 1.82
Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol (1991) 1.82
Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev (1988) 1.80
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol (2008) 1.79
bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med (1996) 1.79
Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol (1998) 1.75
Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils. J Exp Med (1998) 1.75
IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol (2001) 1.74
Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol (1979) 1.74
New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun (1990) 1.71
Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy (2008) 1.70
Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest (1997) 1.69
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun (1994) 1.67
IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide. J Immunol (1988) 1.66
Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J Immunol (1986) 1.66
The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis. J Immunol (1988) 1.64
A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol (1993) 1.62
Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J Immunol (1985) 1.60
In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol (2001) 1.59
Induction of an IgE response in mice by Nippostrongylus brasiliensis: characterization of lymphoid cells with intracytoplasmic or surface IgE. J Immunol (1983) 1.58
Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol (1993) 1.58
A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol (2001) 1.58
Gastrointestinal eosinophils. Immunol Rev (2001) 1.57
The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol (2001) 1.56
Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J Immunol (2000) 1.52
Mouse immunoglobulin D: construction and characterization of a cloned delta chain cDNA. Proc Natl Acad Sci U S A (1980) 1.50
Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol (2001) 1.50
Production of BSF-1 during an in vivo, T-dependent immune response. J Immunol (1986) 1.47
Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev (2001) 1.45
Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol (1992) 1.45
Crosslinkage of B lymphocyte surface immunoglobulin by anti-Ig or antigen induces prolonged oscillation of intracellular ionized calcium. J Exp Med (1987) 1.43
Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells. J Exp Med (1990) 1.43
IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J Immunol (1995) 1.43
Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol (1997) 1.42
Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol (2001) 1.41
Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation. J Immunol (1978) 1.41
Preparation and characterization of monoclonal antibodies to the trichothecene mycotoxin T-2. Appl Environ Microbiol (1985) 1.41
Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol (2000) 1.39
Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem Biophys Res Commun (1996) 1.36
IFN inhibits inflammatory responses and protective immunity in mice infected with the nematode parasite, Nippostrongylus brasiliensis. J Immunol (1993) 1.36
Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. J Immunol (2001) 1.34
In vivo activation of naive T cells by antigen-presenting B cells. J Immunol (1994) 1.32
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
Increased frequency of interleukin 4-producing T cells as a result of polyclonal priming. Use of a single-cell assay to detect interleukin 4-producing cells. Eur J Immunol (1991) 1.31
Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol (1991) 1.29
Trichuris muris: host intestinal epithelial cell hyperproliferation during chronic infection is regulated by interferon-gamma. Exp Parasitol (1999) 1.29
In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties. J Immunol (1986) 1.27
Ig mu-epsilon isotype switch in IL-4-treated human B lymphoblastoid cells. Evidence for a sequential switch. J Immunol (1992) 1.26
T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells. J Immunol (1985) 1.26
Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy (2005) 1.26
Molecular characterization of two murine eosinophil beta chemokine receptors. J Immunol (1995) 1.26
Heligmosomoides polygyrus: CD4+ but not CD8+ T cells regulate the IgE response and protective immunity in mice. Exp Parasitol (1991) 1.25
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J Immunol (1996) 1.25
Immunoglobulin secretion by human splenic lymphocytes in vitro: the effects of antibodies to IgM and IgD. J Immunol (1978) 1.24
IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching. J Immunol (1993) 1.24
Purified Fc epsilon R+ bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a, or ionomycin. J Immunol (1991) 1.24
Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int Arch Allergy Appl Immunol (1991) 1.23
IL-3 promotes production of IL-4 by splenic non-B, non-T cells in response to Fc receptor cross-linkage. J Immunol (1990) 1.23
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23